Gala Health
GLP-1 and hormone health in all 50 states
Telehealth platform offering compounded tirzepatide from $179/mo, microdosed GLP-1 from $149/mo, and brand-name Ozempic, with licensed providers in all 50 states and hormone therapy options.
Advertising disclosure: We may earn a commission if you sign up through this link, at no additional cost to you. This does not influence our ratings or recommendations — how we make money.
Medications Available
Pros
- Licensed providers in all 50 states
- Microdosing option at $149/mo for patients who want a lower-dose approach
- Compounded tirzepatide at $179/mo on the yearly plan
- Hormone therapy (estradiol, progesterone, non-hormonal options) available alongside GLP-1s
- No insurance required, no membership fees advertised
- Wegovy pill listed as coming soon
Cons
- Brand-name Ozempic priced at $1,299/mo — far above every other channel we track
- Best compounded pricing requires a full-year commitment
- Compounded medications are not FDA-approved
- Gala states it does not practice medicine and is not a pharmacy
- No coaching or behavioral support included
- Refund and guarantee terms not published
Compare Gala Health With
See how Gala Health stacks up against other providers
About Gala Health
Gala Health (operating as Gala GLP-1) is a telehealth platform connecting adults in all 50 states with licensed providers for prescription weight management and hormone health. Per its own terms of service, Gala facilitates telehealth consultations and does not itself practice medicine or operate as a pharmacy — clinical decisions rest with the independent licensed provider in your state, and medication is dispensed by partner pharmacies.
Gala is unusual in this category for pairing GLP-1 therapy with hormone health services in one platform, which may appeal to patients — particularly perimenopausal and menopausal women — managing both at once.
How It Works
- Health Assessment — Complete an online form covering medical background, habits, and goals
- Provider Review — A licensed provider in your state reviews and recommends a course of action
- Video Visit If Required — Depending on your state’s laws and the medication, a video visit may be needed
- Pharmacy Fulfillment — If appropriate, medication is ordered from a partner pharmacy
- Ongoing Care — Follow-ups and dose adjustments handled through in-platform chat
Pricing (July 2026)
| Medication | Price | Notes |
|---|---|---|
| Compounded GLP-1/GIP (tirzepatide) | $179/mo | Yearly plan |
| Compounded GLP-1/GIP (tirzepatide) | $199/mo | 3-month plan |
| Microdosed GLP-1/GIP | $149/mo | Lower-dose approach |
| Ozempic (brand-name) | $1,299/mo | Full retail cash price |
| Wegovy pill | Coming soon | Not yet priced |
No insurance required. No membership fees advertised.
A Warning on the Brand-Name Pricing
Gala lists brand-name Ozempic at $1,299/month. Do not pay this.
Every other brand-name channel we track is dramatically cheaper for FDA-approved GLP-1 medication:
| Channel | Brand-Name Price |
|---|---|
| NovoCare | $199/mo intro pricing |
| TrumpRx.gov | ~$350/mo |
| LillyDirect (Zepbound) | $299–449/mo |
| Gala Health (Ozempic) | $1,299/mo |
If you want brand-name semaglutide, go directly to NovoCare or a manufacturer-partnered telehealth provider. Gala’s value proposition is its compounded and microdosing tiers, not its brand-name offering.
The Microdosing Angle
Gala’s $149/mo microdosed GLP-1/GIP option is its most differentiated product. Microdosing — using doses below the standard therapeutic range — has grown popular among patients seeking appetite and metabolic benefits with fewer gastrointestinal side effects, and among those tapering down from full doses.
Be clear-eyed about the evidence: the pivotal trials establishing GLP-1 efficacy (STEP for semaglutide, SURMOUNT for tirzepatide) studied standard doses of FDA-approved products. Microdosing protocols are not FDA-approved, are not backed by equivalent trial data, and should not be expected to produce trial-level weight loss results.
Important Compounding Context
Gala’s compounded medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness, or quality. With the semaglutide and tirzepatide shortages resolved and FDA enforcement against compounded GLP-1 marketing escalating through 2026, committing to a full-year prepaid compounded plan carries regulatory risk that a month-to-month arrangement does not. Read our guide to compounded GLP-1 medications first.
Who Is This Best For?
- Patients who want GLP-1 and hormone therapy managed on one platform
- Those interested in a microdosing protocol
- Patients in states where other providers have limited coverage
- People comfortable with a yearly commitment for the best compounded rate
Who Should Look Elsewhere?
- Anyone seeking brand-name GLP-1s — the Ozempic pricing is not competitive
- Patients who want coaching or structured behavioral support
- Those who want month-to-month pricing without a long commitment
- Patients who want published refund terms before enrolling
The Bottom Line
Gala Health’s compounded and microdosing tiers are reasonably priced, all-50-state coverage is genuinely useful, and bundling hormone therapy with GLP-1 care fills a real need for patients managing both. The brand-name Ozempic listing at $1,299/mo is the outlier and should be ignored — better options exist at a quarter of that price. Treat Gala as a compounded provider with a microdosing specialty, and evaluate it on that basis.
Last updated: July 2026
Last verified: July 2026
Ready to try Gala Health?
Compare with other providers or visit their website to get started.